Blumenauer discusses the role he and other legislators play in expanding access to psychedelics, and what the rest of the country might learn from Oregon.
Plus: Breakthrough Therapies Act and more trouble at atai
1
Fritzsche discusses how potency testing works and the future of psilocybin in Oregon.
4
Plus: New bills in Vermont and Iowa as Utah’s bill stalls, and billing insurance for psychedelic therapy
Robbins discusses bridging traditional knowledge with Western science.
2
Plus: Beckley receives FDA approval for phase IIb 5-MeO-DMT study and Last Week Tonight delves into psychedelics
1
We asked OpenAI's chatbot for its insights on psychedelic therapy.
3
Plus: UK psychedelics ad campaign, and sociability and psychedelics
2
See all

The Microdose